Logo image of JCI

JOHNSON CONTROLS INTERNATION (JCI) Stock Fundamental Analysis

USA - NYSE:JCI - IE00BY7QL619 - Common Stock

110.56 USD
+2.71 (+2.51%)
Last: 10/15/2025, 12:12:10 PM
Fundamental Rating

4

JCI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. There are concerns on the financial health of JCI while its profitability can be described as average. While showing a medium growth rate, JCI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year JCI was profitable.
JCI had a positive operating cash flow in the past year.
Each year in the past 5 years JCI has been profitable.
Each year in the past 5 years JCI had a positive operating cash flow.
JCI Yearly Net Income VS EBIT VS OCF VS FCFJCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.14%, JCI is in line with its industry, outperforming 43.90% of the companies in the same industry.
With a Return On Equity value of 14.09%, JCI perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
JCI's Return On Invested Capital of 6.37% is on the low side compared to the rest of the industry. JCI is outperformed by 70.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JCI is significantly below the industry average of 12.70%.
The 3 year average ROIC (6.34%) for JCI is below the current ROIC(6.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.14%
ROE 14.09%
ROIC 6.37%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
JCI Yearly ROA, ROE, ROICJCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JCI's Profit Margin of 11.11% is fine compared to the rest of the industry. JCI outperforms 65.85% of its industry peers.
JCI's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 12.98%, JCI perfoms like the industry average, outperforming 53.66% of the companies in the same industry.
JCI's Operating Margin has improved in the last couple of years.
JCI has a better Gross Margin (38.13%) than 68.29% of its industry peers.
In the last couple of years the Gross Margin of JCI has grown nicely.
Industry RankSector Rank
OM 12.98%
PM (TTM) 11.11%
GM 38.13%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
JCI Yearly Profit, Operating, Gross MarginsJCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JCI is destroying value.
JCI has less shares outstanding than it did 1 year ago.
JCI has less shares outstanding than it did 5 years ago.
JCI has a worse debt/assets ratio than last year.
JCI Yearly Shares OutstandingJCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
JCI Yearly Total Debt VS Total AssetsJCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.21 indicates that JCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of JCI (2.21) is worse than 82.93% of its industry peers.
The Debt to FCF ratio of JCI is 3.56, which is a good value as it means it would take JCI, 3.56 years of fcf income to pay off all of its debts.
JCI has a Debt to FCF ratio (3.56) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.61 indicates that JCI is somewhat dependend on debt financing.
JCI has a Debt to Equity ratio (0.61) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3.56
Altman-Z 2.21
ROIC/WACC0.89
WACC7.17%
JCI Yearly LT Debt VS Equity VS FCFJCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.96 indicates that JCI may have some problems paying its short term obligations.
JCI has a Current ratio of 0.96. This is amonst the worse of the industry: JCI underperforms 92.68% of its industry peers.
JCI has a Quick Ratio of 0.96. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
JCI's Quick ratio of 0.81 is on the low side compared to the rest of the industry. JCI is outperformed by 75.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.81
JCI Yearly Current Assets VS Current LiabilitesJCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

JCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.91%, which is quite good.
The Earnings Per Share has been growing by 13.04% on average over the past years. This is quite good.
JCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.43%.
JCI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.86% yearly.
EPS 1Y (TTM)8.91%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%-7.89%
Revenue 1Y (TTM)-25.43%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-16.3%

3.2 Future

The Earnings Per Share is expected to grow by 10.97% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.52% on average over the next years.
EPS Next Y1.54%
EPS Next 2Y9.52%
EPS Next 3Y11.88%
EPS Next 5Y10.97%
Revenue Next Year-11.91%
Revenue Next 2Y-3.67%
Revenue Next 3Y-0.78%
Revenue Next 5Y2.52%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JCI Yearly Revenue VS EstimatesJCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
JCI Yearly EPS VS EstimatesJCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.17, which means the current valuation is very expensive for JCI.
68.29% of the companies in the same industry are cheaper than JCI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.49, JCI is valued at the same level.
JCI is valuated rather expensively with a Price/Forward Earnings ratio of 24.84.
JCI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. JCI is more expensive than 68.29% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.99. JCI is around the same levels.
Industry RankSector Rank
PE 29.17
Fwd PE 24.84
JCI Price Earnings VS Forward Price EarningsJCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCI is valued a bit more expensive than the industry average as 78.05% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as JCI.
Industry RankSector Rank
P/FCF 25.03
EV/EBITDA 23.75
JCI Per share dataJCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JCI does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of JCI may justify a higher PE ratio.
PEG (NY)18.9
PEG (5Y)2.24
EPS Next 2Y9.52%
EPS Next 3Y11.88%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.48%, JCI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.24, JCI pays a better dividend. On top of this JCI pays more dividend than 80.49% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.43, JCI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

On average, the dividend of JCI grows each year by 6.63%, which is quite nice.
JCI has been paying a dividend for at least 10 years, so it has a reliable track record.
As JCI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.63%
Div Incr Years4
Div Non Decr Years7
JCI Yearly Dividends per shareJCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

43.93% of the earnings are spent on dividend by JCI. This is a bit on the high side, but may be sustainable.
The dividend of JCI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.93%
EPS Next 2Y9.52%
EPS Next 3Y11.88%
JCI Yearly Income VS Free CF VS DividendJCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B
JCI Dividend Payout.JCI Dividend Payout, showing the Payout Ratio.JCI Dividend Payout.PayoutRetained Earnings

JOHNSON CONTROLS INTERNATION

NYSE:JCI (10/15/2025, 12:12:10 PM)

110.56

+2.71 (+2.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners92.98%
Inst Owner Change-0.16%
Ins Owners0.24%
Ins Owner Change-1.99%
Market Cap72.35B
Analysts74.07
Price Target115.59 (4.55%)
Short Float %3.88%
Short Ratio5.18
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend1.49
Dividend Growth(5Y)6.63%
DP43.93%
Div Incr Years4
Div Non Decr Years7
Ex-Date09-22 2025-09-22 (0.4)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.91%
Min EPS beat(2)2.66%
Max EPS beat(2)3.16%
EPS beat(4)4
Avg EPS beat(4)4.76%
Min EPS beat(4)2.66%
Max EPS beat(4)7.63%
EPS beat(8)6
Avg EPS beat(8)2.5%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)8
Avg EPS beat(16)1.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.76%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)2.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)4
Avg Revenue beat(16)-1.05%
PT rev (1m)0.49%
PT rev (3m)9.36%
EPS NQ rev (1m)0.79%
EPS NQ rev (3m)3.54%
EPS NY rev (1m)0.35%
EPS NY rev (3m)1.53%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 29.17
Fwd PE 24.84
P/S 3.6
P/FCF 25.03
P/OCF 21.51
P/B 4.57
P/tB N/A
EV/EBITDA 23.75
EPS(TTM)3.79
EY3.43%
EPS(NY)4.45
Fwd EY4.03%
FCF(TTM)4.42
FCFY3.99%
OCF(TTM)5.14
OCFY4.65%
SpS30.69
BVpS24.19
TBVpS-7.24
PEG (NY)18.9
PEG (5Y)2.24
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 14.09%
ROCE 8.4%
ROIC 6.37%
ROICexc 6.52%
ROICexgc 18.68%
OM 12.98%
PM (TTM) 11.11%
GM 38.13%
FCFM 14.39%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3.56
Debt/EBITDA 2.93
Cap/Depr 66.39%
Cap/Sales 2.36%
Interest Coverage 250
Cash Conversion 101.3%
Profit Quality 129.54%
Current Ratio 0.96
Quick Ratio 0.81
Altman-Z 2.21
F-Score7
WACC7.17%
ROIC/WACC0.89
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)8.91%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%-7.89%
EPS Next Y1.54%
EPS Next 2Y9.52%
EPS Next 3Y11.88%
EPS Next 5Y10.97%
Revenue 1Y (TTM)-25.43%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-16.3%
Revenue Next Year-11.91%
Revenue Next 2Y-3.67%
Revenue Next 3Y-0.78%
Revenue Next 5Y2.52%
EBIT growth 1Y2.68%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year15%
EBIT Next 3Y12.44%
EBIT Next 5Y9.16%
FCF growth 1Y95.01%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y67.36%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%